NCT03224234View on ClinicalTrials.gov

A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

September 18, 2019

Study Completion Date

September 18, 2019

Conditions
Diabetes
Interventions
DEVICE

Insulclock with feedback

Daily information on a smartphone on insulin administration (time and dosing) as well as reminders in the event of missing doses.

DEVICE

Insulclock without feedback

Not feedback on insulin administration.

Trial Locations (1)

30322

Emory Clinic, Emory University Hospital (non-CRN), Emory University Hospital Clinical Research Network, Emory University Hospital Midtown, Grady Health System (non-CRN), Atlanta

All Listed Sponsors
collaborator

Insulcloud S.L.

INDUSTRY

lead

Emory University

OTHER

NCT03224234 - A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 Diabetes | Biotech Hunter | Biotech Hunter